Ochsner has implemented pharmacogenomics, how patients metabolize certain drugs and warnings of possible side effects, into its EHR system so that clinicians can adjust dosages for patients and provide more individualized care, according to a March 16 release from Ochsner.
The health system is one of the first to fully integrate the process into its EHR system.
These tests are part of a pharmacogenomics program Ochsner launched in March 2022. The tests are used in the health system’s cardiology, psychiatry, cancer, rheumatology, pain management and infectious disease departments.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
